Cargando…
Invasive lobular carcinoma: clinicopathological features and subtypes
OBJECTIVE: To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC) and to investigate the impact of histology on axillary lymph node (ALN) involvement in luminal A subtype tumors. METHODS: We retrospectively analyzed patients diagnosed with IL...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258769/ https://www.ncbi.nlm.nih.gov/pubmed/34187216 http://dx.doi.org/10.1177/03000605211017039 |
_version_ | 1783718558368268288 |
---|---|
author | Danzinger, Sabine Hielscher, Nora Izsó, Miriam Metzler, Johanna Trinkl, Carmen Pfeifer, Christian Tendl-Schulz, Kristina Singer, Christian F. |
author_facet | Danzinger, Sabine Hielscher, Nora Izsó, Miriam Metzler, Johanna Trinkl, Carmen Pfeifer, Christian Tendl-Schulz, Kristina Singer, Christian F. |
author_sort | Danzinger, Sabine |
collection | PubMed |
description | OBJECTIVE: To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC) and to investigate the impact of histology on axillary lymph node (ALN) involvement in luminal A subtype tumors. METHODS: We retrospectively analyzed patients diagnosed with ILC or IDC from 2012 to 2016 who underwent surgery. Patients constituted 493 primary early breast cancer cases (82 ILC; 411 IDC). RESULTS: Compared with IDC, ILC tumors were significantly more likely to be grade 2, estrogen receptor- (ER) positive (+), have a lower proliferation rate (Ki67 <14%), and a higher pathological T stage (pT2–4). The luminal A subtype was significantly more common in ILC compared with IDC. In a multivariate regression model, grade 2, ER+, progesterone receptor-positive, pT2, and pT3 were significantly associated with ILC. Additionally, with the luminal A subtype, ALN involvement (pathological node stage (pN)1–3) was significantly more frequent with ILC versus IDC. CONCLUSIONS: Our data suggest that grade 2, positive hormone receptor status, and higher pathological T stage are associated with ILC. With the luminal A subtype, ALN involvement was more frequent with ILC versus IDC. |
format | Online Article Text |
id | pubmed-8258769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-82587692021-07-16 Invasive lobular carcinoma: clinicopathological features and subtypes Danzinger, Sabine Hielscher, Nora Izsó, Miriam Metzler, Johanna Trinkl, Carmen Pfeifer, Christian Tendl-Schulz, Kristina Singer, Christian F. J Int Med Res Retrospective Clinical Research Report OBJECTIVE: To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC) and to investigate the impact of histology on axillary lymph node (ALN) involvement in luminal A subtype tumors. METHODS: We retrospectively analyzed patients diagnosed with ILC or IDC from 2012 to 2016 who underwent surgery. Patients constituted 493 primary early breast cancer cases (82 ILC; 411 IDC). RESULTS: Compared with IDC, ILC tumors were significantly more likely to be grade 2, estrogen receptor- (ER) positive (+), have a lower proliferation rate (Ki67 <14%), and a higher pathological T stage (pT2–4). The luminal A subtype was significantly more common in ILC compared with IDC. In a multivariate regression model, grade 2, ER+, progesterone receptor-positive, pT2, and pT3 were significantly associated with ILC. Additionally, with the luminal A subtype, ALN involvement (pathological node stage (pN)1–3) was significantly more frequent with ILC versus IDC. CONCLUSIONS: Our data suggest that grade 2, positive hormone receptor status, and higher pathological T stage are associated with ILC. With the luminal A subtype, ALN involvement was more frequent with ILC versus IDC. SAGE Publications 2021-06-29 /pmc/articles/PMC8258769/ /pubmed/34187216 http://dx.doi.org/10.1177/03000605211017039 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Retrospective Clinical Research Report Danzinger, Sabine Hielscher, Nora Izsó, Miriam Metzler, Johanna Trinkl, Carmen Pfeifer, Christian Tendl-Schulz, Kristina Singer, Christian F. Invasive lobular carcinoma: clinicopathological features and subtypes |
title | Invasive lobular carcinoma: clinicopathological features and subtypes |
title_full | Invasive lobular carcinoma: clinicopathological features and subtypes |
title_fullStr | Invasive lobular carcinoma: clinicopathological features and subtypes |
title_full_unstemmed | Invasive lobular carcinoma: clinicopathological features and subtypes |
title_short | Invasive lobular carcinoma: clinicopathological features and subtypes |
title_sort | invasive lobular carcinoma: clinicopathological features and subtypes |
topic | Retrospective Clinical Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258769/ https://www.ncbi.nlm.nih.gov/pubmed/34187216 http://dx.doi.org/10.1177/03000605211017039 |
work_keys_str_mv | AT danzingersabine invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes AT hielschernora invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes AT izsomiriam invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes AT metzlerjohanna invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes AT trinklcarmen invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes AT pfeiferchristian invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes AT tendlschulzkristina invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes AT singerchristianf invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes |